von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter

VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived g...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular biochemistry Vol. 85; no. 3; pp. 490 - 495
Main Authors Rafty, Louise A., Khachigian, Levon M.
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 2002
Subjects
Online AccessGet full text

Cover

Loading…
Abstract VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc.
AbstractList VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc.
VHL is the causative gene for von Hippel-Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet-derived growth factor B-chain (PDGF-B). The regulatory mechanisms underlying pVHL suppression of PDGF-B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady-state PDGF-B mRNA expression and PDGF-B promoter-dependent transcription in WKY12-22 cells. Transient transfection analysis utilizing PDGF-B promoter-chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF-B expression is mediated via the Sp1-binding element in the proximal region of the PDGF-B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF-B promoter. We show that Sp1 can rescue PDGF-B promoter activity and endogenous PDGF-B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF-B transcription.
Abstract VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc.
Author Rafty, Louise A.
Khachigian, Levon M.
Author_xml – sequence: 1
  givenname: Louise A.
  surname: Rafty
  fullname: Rafty, Louise A.
  organization: Centre for Thrombosis and Vascular Research, University of New South Wales, Australia
– sequence: 2
  givenname: Levon M.
  surname: Khachigian
  fullname: Khachigian, Levon M.
  email: L.Khachigian@unsw.edu.au
  organization: Centre for Thrombosis and Vascular Research, University of New South Wales, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11967988$$D View this record in MEDLINE/PubMed
BookMark eNp1kctuEzEYhS1URNOWBS-AvEJiYWqPZ8bjJQkkbRUBakGwszyefxKXudX2pOkT8Zo4F2DFyrfvnGP7nKGTru8AoVeMvmOUJpf3powTliXP0IRRKUiap-kJmlDBKUk4S07Rmff3lFIpefICnTImcyGLYoJ-bfoOX9lhgIYsbVfpEYex7R324zA48D5OB9cHsB12sN8Bj4dGB2ggkAqc3UCFV65_DGtcaxOiYErMWkfBCjrAsN2rbMzZWI3DGvDdwHAZw2y3wtGmhS7giO-OYtbWtrrBXz4s5mS6W7cx3V2g57VuPLw8jufo2_zj19kVWX5eXM_eL4nhmUxInUJp6oyWJcuMBMEMlZoKmUMlTFkJqeOzeZ1LzvO8MqUscp1W8edkwqq8YPwcvTn4xuCHEXxQrfUGmkZ30I9eCSZYkTAZwbcH0Ljeewe1Gly8uHtSjKpdKyq2ovatRPb10XQsW6j-kccaInB5AB5tA0__d1I3s-kfS3JQWB9g-1eh3U-VCy4y9f3TQv2Qt8k8nS3VLf8NgJqqdQ
CitedBy_id crossref_primary_10_1038_sj_onc_1210474
crossref_primary_10_1158_1535_7163_MCT_08_0013
crossref_primary_10_1002_path_2689
crossref_primary_10_1111_febs_13148
crossref_primary_10_1152_ajplung_00026_2003
crossref_primary_10_1074_jbc_M109_002691
crossref_primary_10_1159_000075346
crossref_primary_10_1002_ijc_31196
crossref_primary_10_1038_nrc2502
crossref_primary_10_1038_nrc3844
crossref_primary_10_1016_j_bone_2019_03_006
crossref_primary_10_1016_j_bbcan_2009_01_001
Cites_doi 10.1073/pnas.93.5.1770
10.1074/jbc.271.20.11792
10.1074/jbc.271.24.14584
10.1126/science.284.5413.455
10.1128/MCB.17.9.5629
10.1126/science.8493574
10.1074/jbc.271.6.3025
10.1093/hmg/3.8.1303
10.1128/MCB.19.2.1486
10.1016/S0959-437X(00)00152-0
10.1073/pnas.93.20.10595
10.1093/hmg/3.12.2169
10.1016/S0021-9258(17)31695-2
10.1074/jbc.273.41.26277
10.1073/pnas.92.14.6459
10.1006/bbrc.1999.1767
ContentType Journal Article
Copyright Copyright © 2002 Wiley‐Liss, Inc.
Copyright 2002 Wiley-Liss, Inc.
Copyright_xml – notice: Copyright © 2002 Wiley‐Liss, Inc.
– notice: Copyright 2002 Wiley-Liss, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/jcb.10152
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1097-4644
EndPage 495
ExternalDocumentID 10_1002_jcb_10152
11967988
JCB10152
ark_67375_WNG_X9R2F4CL_R
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NSW State Department of Health
– fundername: National Health and Medical Research Council of Australia
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH6
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V8K
W8V
W99
WBKPD
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WSB
WXSBR
WYISQ
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3592-f4ebcf50bb15c9e71c09a0796ed7cbd79a7983f693366dcb986a4d152921d6813
IEDL.DBID DR2
ISSN 0730-2312
IngestDate Fri Aug 16 12:21:14 EDT 2024
Fri Aug 23 01:01:02 EDT 2024
Sat Sep 28 07:48:08 EDT 2024
Sat Aug 24 00:56:59 EDT 2024
Wed Oct 30 09:50:56 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright 2002 Wiley-Liss, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3592-f4ebcf50bb15c9e71c09a0796ed7cbd79a7983f693366dcb986a4d152921d6813
Notes National Health and Medical Research Council of Australia
ark:/67375/WNG-X9R2F4CL-R
istex:382F899DF40DBD4AB4B35EC270B3BF63BEE4784B
ArticleID:JCB10152
NSW State Department of Health
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 11967988
PQID 71718219
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_71718219
crossref_primary_10_1002_jcb_10152
pubmed_primary_11967988
wiley_primary_10_1002_jcb_10152_JCB10152
istex_primary_ark_67375_WNG_X9R2F4CL_R
PublicationCentury 2000
PublicationDate 2002
2002-00-00
2002-01-00
20020101
PublicationDateYYYYMMDD 2002-01-01
PublicationDate_xml – year: 2002
  text: 2002
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Journal of cellular biochemistry
PublicationTitleAlternate J. Cell. Biochem
PublicationYear 2002
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References Stebbins CE, Kaelin WG Jr, Pavletich NP. 1999. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284(5413): 455-461.
Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD. 1996. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 93(5): 1770-1775.
Scarpati EM, DiCorleto PE. 1996. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J Biol Chem 271(6): 3025-3032.
Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP. 1997. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity. Mol Cell Biol 17(9): 5629-5639.
Cohen HT, Zhou M, Welsh AM, Zarghamee S, Scholz H, Mukhopadhyay D, Kishida T, Zbar B, Knebelmann B, Sukhatme VP. 1999. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem Biophys Res Commun 266(1): 43-50.
Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA. 1994. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3(12): 2169-2173.
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112): 1317-1320.
Pal S, Claffey KP, Cohen HT, Mukhopadhyay D. 1998. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem 273(41): 26277-26280.
Ivan M, Kaelin WG Jr. 2001. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 11(1): 27-34.
Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D. 1996. Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56(10): 2299-2301.
Duan DR, Humphrey JS, Chen DY, Weng Y, Sukegawa J, Lee S, Gnarra JR, Linehan WM, Klausner RD. 1995. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92(14): 6459-6463.
Trejo SR, Fahl WE, Ratner L. 1996. c-sis/PDGF-B promoter transactivation by the Yax protein of human T-cell leukemia virus type 1. J Biol Chem 271(24): 14581-14590.
Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. 1994. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3(8): 1303-1308.
Silverman ES, Khachigian LM, Lindner V, Williams AJ, Collins T. 1997. Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am J Pathol 273(3 Pt 2): H1415-H1426.
Liang Y, Robinson DF, Dennig J, Suske G, Fahl WE. 1996. Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J Biol Chem 271(20): 11792-11797.
Khachigian LM, Fries JW, Benz MW, Bonthron DT, Collins T. 1994. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells. J Biol Chem 269(36): 22647-22656.
Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93(20): 10595-10599.
Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD. 1999. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 19(2): 1486-1497.
1995; 92
1994; 269
1999; 19
1997; 273
1993; 260
1996; 93
1996; 271
1997; 17
1999; 284
1999; 266
2001; 11
1994; 3
1996; 56
1998; 273
Trejo SR (e_1_2_6_19_1) 1996; 271
e_1_2_6_10_1
Lee S (e_1_2_6_11_1) 1999; 19
Silverman ES (e_1_2_6_17_1) 1997; 273
e_1_2_6_9_1
Siemeister G (e_1_2_6_16_1) 1996; 56
Mukhopadhyay D (e_1_2_6_13_1) 1997; 17
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
Khachigian LM (e_1_2_6_8_1) 1994; 269
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_18_1
e_1_2_6_15_1
References_xml – volume: 93
  start-page: 10595
  issue: 20
  year: 1996
  end-page: 10599
  article-title: Negative regulation of hypoxia‐inducible genes by the von Hippel‐Lindau protein
  publication-title: Proc Natl Acad Sci USA
– volume: 19
  start-page: 1486
  issue: 2
  year: 1999
  end-page: 1497
  article-title: Transcription‐dependent nuclear‐cytoplasmic trafficking is required for the function of the von Hippel‐Lindau tumor suppressor protein
  publication-title: Mol Cell Biol
– volume: 3
  start-page: 2169
  issue: 12
  year: 1994
  end-page: 2173
  article-title: Somatic mutations of the von Hippel‐Lindau disease tumour suppressor gene in non‐familial clear cell renal carcinoma
  publication-title: Hum Mol Genet
– volume: 269
  start-page: 22647
  issue: 36
  year: 1994
  end-page: 22656
  article-title: Novel cis‐acting elements in the human platelet‐derived growth factor B‐chain core promoter that mediate gene expression in cultured vascular endothelial cells
  publication-title: J Biol Chem
– volume: 271
  start-page: 11792
  issue: 20
  year: 1996
  end-page: 11797
  article-title: Transcriptional regulation of the SIS/PDGF‐B gene in human osteosarcoma cells by the Sp family of transcription factors
  publication-title: J Biol Chem
– volume: 3
  start-page: 1303
  issue: 8
  year: 1994
  end-page: 1308
  article-title: Identification of intragenic mutations in the von Hippel‐Lindau disease tumour suppressor gene and correlation with disease phenotype
  publication-title: Hum Mol Genet
– volume: 273
  start-page: 26277
  issue: 41
  year: 1998
  end-page: 26280
  article-title: Activation of Sp1‐mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta
  publication-title: J Biol Chem
– volume: 271
  start-page: 3025
  issue: 6
  year: 1996
  end-page: 3032
  article-title: Identification of a thrombin response element in the human platelet‐derived growth factor B‐chain (c‐sis) promoter
  publication-title: J Biol Chem
– volume: 271
  start-page: 14581
  issue: 24
  year: 1996
  end-page: 14590
  article-title: c‐sis/PDGF‐B promoter transactivation by the Yax protein of human T‐cell leukemia virus type 1
  publication-title: J Biol Chem
– volume: 273
  start-page: H1415
  issue: 3 Pt 2
  year: 1997
  end-page: H1426
  article-title: Inducible PDGF A‐chain transcription in smooth muscle cells is mediated by Egr‐1 displacement of Sp1 and Sp3
  publication-title: Am J Pathol
– volume: 11
  start-page: 27
  issue: 1
  year: 2001
  end-page: 34
  article-title: The von Hippel‐Lindau tumor suppressor protein
  publication-title: Curr Opin Genet Dev
– volume: 17
  start-page: 5629
  issue: 9
  year: 1997
  end-page: 5639
  article-title: The von Hippel‐Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity
  publication-title: Mol Cell Biol
– volume: 260
  start-page: 1317
  issue: 5112
  year: 1993
  end-page: 1320
  article-title: Identification of the von Hippel‐Lindau disease tumor suppressor gene
  publication-title: Science
– volume: 266
  start-page: 43
  issue: 1
  year: 1999
  end-page: 50
  article-title: An important von Hippel‐Lindau tumor suppressor domain mediates Sp1‐binding and self‐association
  publication-title: Biochem Biophys Res Commun
– volume: 92
  start-page: 6459
  issue: 14
  year: 1995
  end-page: 6463
  article-title: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations
  publication-title: Proc Natl Acad Sci USA
– volume: 284
  start-page: 455
  issue: 5413
  year: 1999
  end-page: 461
  article-title: Structure of the VHL‐ElonginC‐ElonginB complex: implications for VHL tumor suppressor function
  publication-title: Science
– volume: 56
  start-page: 2299
  issue: 10
  year: 1996
  end-page: 2301
  article-title: Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel‐Lindau tumor suppressor protein
  publication-title: Cancer Res
– volume: 93
  start-page: 1770
  issue: 5
  year: 1996
  end-page: 1775
  article-title: Nuclear/cytoplasmic localization of the von Hippel‐Lindau tumor suppressor gene product is determined by cell density
  publication-title: Proc Natl Acad Sci USA
– ident: e_1_2_6_10_1
  doi: 10.1073/pnas.93.5.1770
– volume: 56
  start-page: 2299
  issue: 10
  year: 1996
  ident: e_1_2_6_16_1
  article-title: Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel‐Lindau tumor suppressor protein
  publication-title: Cancer Res
  contributor:
    fullname: Siemeister G
– volume: 273
  start-page: H1415
  issue: 3
  year: 1997
  ident: e_1_2_6_17_1
  article-title: Inducible PDGF A‐chain transcription in smooth muscle cells is mediated by Egr‐1 displacement of Sp1 and Sp3
  publication-title: Am J Pathol
  contributor:
    fullname: Silverman ES
– ident: e_1_2_6_12_1
  doi: 10.1074/jbc.271.20.11792
– volume: 271
  start-page: 14581
  issue: 24
  year: 1996
  ident: e_1_2_6_19_1
  article-title: c‐sis/PDGF‐B promoter transactivation by the Yax protein of human T‐cell leukemia virus type 1
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.24.14584
  contributor:
    fullname: Trejo SR
– ident: e_1_2_6_18_1
  doi: 10.1126/science.284.5413.455
– volume: 17
  start-page: 5629
  issue: 9
  year: 1997
  ident: e_1_2_6_13_1
  article-title: The von Hippel‐Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.17.9.5629
  contributor:
    fullname: Mukhopadhyay D
– ident: e_1_2_6_9_1
  doi: 10.1126/science.8493574
– ident: e_1_2_6_15_1
  doi: 10.1074/jbc.271.6.3025
– ident: e_1_2_6_3_1
  doi: 10.1093/hmg/3.8.1303
– volume: 19
  start-page: 1486
  issue: 2
  year: 1999
  ident: e_1_2_6_11_1
  article-title: Transcription‐dependent nuclear‐cytoplasmic trafficking is required for the function of the von Hippel‐Lindau tumor suppressor protein
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.2.1486
  contributor:
    fullname: Lee S
– ident: e_1_2_6_7_1
  doi: 10.1016/S0959-437X(00)00152-0
– ident: e_1_2_6_6_1
  doi: 10.1073/pnas.93.20.10595
– ident: e_1_2_6_5_1
  doi: 10.1093/hmg/3.12.2169
– volume: 269
  start-page: 22647
  issue: 36
  year: 1994
  ident: e_1_2_6_8_1
  article-title: Novel cis‐acting elements in the human platelet‐derived growth factor B‐chain core promoter that mediate gene expression in cultured vascular endothelial cells
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)31695-2
  contributor:
    fullname: Khachigian LM
– ident: e_1_2_6_14_1
  doi: 10.1074/jbc.273.41.26277
– ident: e_1_2_6_4_1
  doi: 10.1073/pnas.92.14.6459
– ident: e_1_2_6_2_1
  doi: 10.1006/bbrc.1999.1767
SSID ssj0009932
Score 1.7829885
Snippet VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of...
VHL is the causative gene for von Hippel-Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of...
Abstract VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 490
SubjectTerms Animals
Binding Sites
Cells, Cultured
Chloramphenicol O-Acetyltransferase - genetics
Chloramphenicol O-Acetyltransferase - metabolism
Down-Regulation
gene expression
Gene Expression Regulation - physiology
Ligases - genetics
Ligases - metabolism
Muscle, Smooth, Vascular - cytology
Muscle, Smooth, Vascular - physiology
platelet-derived growth factor B-chain
Promoter Regions, Genetic
Proto-Oncogene Proteins c-sis - genetics
Proto-Oncogene Proteins c-sis - metabolism
Rats
Rats, Inbred WKY
Recombinant Proteins - genetics
Recombinant Proteins - metabolism
Repressor Proteins - genetics
Repressor Proteins - metabolism
Sp1 Transcription Factor - metabolism
transcription
Transcription, Genetic
Transfection
Tumor Suppressor Proteins
Ubiquitin-Protein Ligases
von Hippel-Lindau protein
Von Hippel-Lindau Tumor Suppressor Protein
Title von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter
URI https://api.istex.fr/ark:/67375/WNG-X9R2F4CL-R/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.10152
https://www.ncbi.nlm.nih.gov/pubmed/11967988
https://search.proquest.com/docview/71718219
Volume 85
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqIgQXfgqU8GshhLikzY8Tx-LEbtmuKqjQQsUekCzbcWhom42yyapw4hF4E96JJ2Fsb3ZVBBLiZsV24tifPTPJzDcIPQ1klqlcF74w8VskK2JfgKT24RrISy1IbHkL3hym4yNyME2mG-hFHwvj-CFWH9zMzrDntdngQs5316Shn5U0pmdizt8wpsada2-ypo4CuWv_IACCfdBhop5VKIh2Vz0vyKJLZlrP_6RoXtRbreAZXUcf-yE7f5OTna6VO-rrb2yO__lON9C1pUKKXzoE3UQbutpCl12Kyi9b6Mqwzwh3C_1YzCo8Lutan_789t1a8x1uu7NZg-ddbT1qoWiZH8oKN87HVs9xfQoKLeADOuUA-IXO8Sew_ttj7LL94AHUqGMBnQDOGuvzpXduhRelwKCi4nd1iGVpI3Cwdh7vGJqbKjMx5Rm8wtu9_RHcaGCuAAB1cxsdjV69H479ZcIHX8UJi_yCaKmKJJAyTBTTNFQBEwFlqc6pkjllgrIsLlIWx2maK8myVJAcpotFYZ5mYXwHbVazSt9FWFMiaUiUFkFMVCQZSbSJSipkVmSM5B560i89rx2vB3cMzhGHVeB2FTz0zIJi1UI0J8YRjib8w-E-n7JJNCLD13ziocc9ajisifnnIio96-YcrGWw4ELmoW0HpvXT4OwzZHEeem4h8fdh8IPhwBbu_XvT--iqzVtjPxY9QJtt0-mHoD618pHdJ78AF2wbZQ
link.rule.ids 315,783,787,1378,4031,27935,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFLWqVqi8sJQtbLUQQrykzeIslnhhpkyHMh2hoRXzgizbcWhom0SZZCg88Qn8Cf_El3DtTGZUBBLizfKSeDn2vbavz0XoqSPiWCYqtbl-v0Xi1Lc5SGob4kBeKk58w1twOA6Hx-RgGkzX0IvuLUzLD7E8cNMzw6zXeoLrA-ndFWvoJyn03jOABXgDpruvHTfsTVbkUSB5zR0CpNigxXgdr5Dj7S6LXpJGG7pjL_6kal7WXI3oGVxHH7pKtxYnpztNLXbk19_4HP-3VTfQtYVOil-2ILqJ1lS-ha60Xiq_bKHNfucU7hb6MS9yPMzKUp39_PbdbOgbXDfnRYVnTWmMaiFoyB-yHFetma2a4fIMdFqACBRKAPNzleCPVfG5PsGtwx_cgxR5wqEQIFphdbEw0M3xPOMYtFT8rnSxyMwjHKxao3cM2XWS7pnsHJrwdm9_AB_q6RjAoKpuo-PBq6P-0F74fLClH1DPTokSMg0cIdxAUhW50qHciWiokkiKJKI8orGfhtT3wzCRgsYhJwl0F_XcJIxd_w5az4tc3UNYRURELpGKOz6RnqAkUPphUiriNKYksdCTbuxZ2VJ7sJbE2WMwCsyMgoWeGVQsc_DqVNvCRQF7P95nUzrxBqQ_YhMLbXewYTAm-tqF56poZgw2zLCJc6mF7rZoWv0Nlj_NF2eh5wYTf68GO-j3TOD-v2fdRpvDo8MRG70ev3mArho3Nubs6CFar6tGPQJtqhaPzaT5BZhVH30
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFLWqViwvLGULWy2EEC9psziLxRMzJR1KGVUDFfOAZNmOQ4e2mSiTjApPfAJ_wj_xJVzbkxkVgYR4ixI7cexj33OT63MReuqJNJW5Klyu92-RtAhdDpbahXNgLxUnodEteDuMB0dkfxyN19CLbi-M1YdYfnDTM8Os13qCV3mxsxIN_SyFdj0jWH83SAzMVzOi0Uo7Cgyv-YUAEHaBxASdrJAX7CyrXjBGG7pfz__ENC8SV2N5suvoY9dmG3Byst02Ylt-_U3O8T9f6ga6tmCk-KWF0E20pspNdMnmqPyyia70u5Rwt9CP-bTEg0lVqdOf374bd77FTXs2rfGsrUxILRwa6YdJiWsbZKtmuDoFRgsAgUo5IH6ucvwJ3P_mGNt0P7gHV-Qxh0qAZ4XV-SI8t8TzCcfAUfG7ysdiYrbgYGVD3jEU15d0x0zO4BUOd_cyuFFPnwEEqvo2Ospeve8P3EXGB1eGEQ3cgighi8gTwo8kVYkvPcq9hMYqT6TIE8oTmoZFTMMwjnMpaBpzkkN30cDP49QP76D1clqqewirhIjEJ1JxLyQyEJRESm9LKkRapJTkDnrSDT2rrLAHsxLOAYNRYGYUHPTMgGJZgtcnOhIuidiH4R4b01GQkf4BGzloq0MNgzHRP114qabtjIG7DC6cTx1014Jp9TRY_LRanIOeG0j8vRlsv98zB_f_vegWuny4m7GD18M3D9BVk8PGfDh6iNabulWPgEo14rGZMr8ANXIeLA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=von+Hippel%E2%80%90Lindau+tumor+suppressor+protein+represses+platelet%E2%80%90derived+growth+factor+B%E2%80%90chain+gene+expression+via+the+Sp1+binding+element+in+the+proximal+PDGF%E2%80%90B+promoter&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Rafty%2C+Louise+A.&rft.au=Khachigian%2C+Levon+M.&rft.date=2002&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0730-2312&rft.eissn=1097-4644&rft.volume=85&rft.issue=3&rft.spage=490&rft.epage=495&rft_id=info:doi/10.1002%2Fjcb.10152&rft.externalDBID=10.1002%252Fjcb.10152&rft.externalDocID=JCB10152
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon